Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections

ABSTRACT Acinetobacter baumannii has emerged as a highly troublesome, global pathogen. Treatment is complicated by high levels of antibiotic resistance, necessitating alternative means to prevent or treat A. baumannii infections. We evaluated an immunotherapeutic approach against A. baumannii, focusing on the surface polysaccharide poly-N-acetyl-β-(1-6)-glucosamine (PNAG). We used a synthetic oligosaccharide of 9 monosaccharide units (9Glc-NH2) conjugated to tetanus toxoid (TT) to induce antibodies in rabbits. In the presence of complement and polymorphonuclear cells, antisera to 9Glc-NH2-TT mediated the killing of A. baumannii S1, a high-PNAG-producing strain, but not its isogenic PNAG-negative, in-frame deletion mutant strain, S1 Δpga. Complementing the pgaABCD locus in trans in the shuttle vector pBAD18kan-ori, plasmid Δpga-c, restored the high levels of killing mediated by antibody to PNAG observed with the wild-type S1 strain. No killing was observed when normal rabbit serum (NRS) or heat-inactivated complement was used. Antiserum to 9Glc-NH2-TT was highly opsonic against an additional four unrelated multidrug-resistant clinical isolates of A. baumannii that synthesize various levels of surface PNAG. Using two clinically relevant models of A. baumannii infection in mice, pneumonia and bacteremia, antisera to 9Glc-NH2-TT significantly reduced levels of A. baumannii in the lungs or blood 2 and 24 h postinfection, respectively, compared to levels of control groups receiving NRS. This was true for all four A. baumannii strains tested. Overall, these results highlight the potential of PNAG as a vaccine component for active immunization or as a target for passive antibody immunotherapy.

[1]  V. Rotimi,et al.  Emergence of Tigecycline and Colistin Resistance in Acinetobacter Species Isolated from Patients in Kuwait Hospitals , 2011, Journal of chemotherapy.

[2]  K. Kaye,et al.  Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  G. Pier,et al.  Synthetic β-(1→6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens , 2009, Infection and Immunity.

[4]  G. Pier,et al.  The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly-β-1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation , 2009, Journal of bacteriology.

[5]  D. Maki,et al.  International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. , 2008, American journal of infection control.

[6]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[7]  A. Nemec.  [Multidrug resistant Acinetobacter baumannii]. , 2008, Klinicka mikrobiologie a infekcni lekarstvi.

[8]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[9]  Carlos C. Goller,et al.  Roles of pgaABCD Genes in Synthesis, Modification, and Export of the Escherichia coli Biofilm Adhesin Poly-β-1,6-N-Acetyl-d-Glucosamine , 2008, Journal of bacteriology.

[10]  J. Calhoun,et al.  Multidrug-resistant Organisms in Military Wounds from Iraq and Afghanistan , 2008, Clinical orthopaedics and related research.

[11]  C. Price,et al.  Epidemiologic, Clinical, and Economic Evaluation of an Outbreak of Clonal Multidrug-Resistant Acinetobacter baumannii Infection in a Surgical Intensive Care Unit , 2007, Infection Control & Hospital Epidemiology.

[12]  J. Quinn,et al.  Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 , 2007, Journal of Clinical Microbiology.

[13]  Y. Carmeli,et al.  Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  J. Patel,et al.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Goldmann,et al.  Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide , 2007, Proceedings of the National Academy of Sciences.

[16]  N. Aronson,et al.  In harm's way: infections in deployed American military forces. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  R. Bonomo,et al.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  T. Pitt,et al.  Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. , 2006, Lancet. Infectious Diseases (Print).

[19]  C. Chu,et al.  Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. , 2005, Chest.

[20]  D. Goldmann,et al.  Comparative Opsonic and Protective Activities of Staphylococcus aureus Conjugate Vaccines Containing Native or Deacetylated Staphylococcal Poly-N-Acetyl-β-(1-6)-Glucosamine , 2005, Infection and Immunity.

[21]  S. Pitlik,et al.  Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002 , 2005, Journal of Hospital Infection.

[22]  D. Rixen,et al.  The long-distance tertiary air transfer and care of tsunami victims: Injury pattern and microbiological and psychological aspects* , 2005, Critical care medicine.

[23]  M. Falagas,et al.  Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria , 2005, BMC infectious diseases.

[24]  L. Danziger,et al.  Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians , 2004, The Annals of pharmacotherapy.

[25]  J. Preston,et al.  The pgaABCD Locus of Escherichia coli Promotes the Synthesis of a Polysaccharide Adhesin Required for Biofilm Formation , 2004, Journal of bacteriology.

[26]  M. Nahm,et al.  Efficiency of a Pneumococcal Opsonophagocytic Killing Assay Improved by Multiplexing and by Coloring Colonies , 2003, Clinical Diagnostic Laboratory Immunology.

[27]  J. Karlowsky,et al.  Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001 , 2003, Antimicrobial Agents and Chemotherapy.

[28]  Donald A. Goldmann,et al.  Immunochemical Properties of the Staphylococcal Poly-N-Acetylglucosamine Surface Polysaccharide , 2002, Infection and Immunity.

[29]  O. Oncul,et al.  Hospital-acquired infections following the 1999 Marmara earthquake. , 2002, The Journal of hospital infection.

[30]  G. Pier,et al.  Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread , 2000, Infection and Immunity.

[31]  D. Goldmann,et al.  Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. , 1999, Science.

[32]  D. Goldmann,et al.  The ica Locus of Staphylococcus epidermidis Encodes Production of the Capsular Polysaccharide/Adhesin , 1998, Infection and Immunity.

[33]  T. Nakae,et al.  Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. , 1991, The Journal of antimicrobial chemotherapy.

[34]  B. Aarabi.  Comparative study of bacteriological contamination between primary and secondary exploration of missile head wounds. , 1987, Neurosurgery.

[35]  R. Weinstein,et al.  Acinetobacter infection. , 2008, The New England journal of medicine.

[36]  John A. Kellen,et al.  Mechanisms of Multidrug Resistance , 1995 .